The Unifying Power of Rare Disease: CurePSP Visits Capitol Hill

Share the Care: Joanna Teters, CurePSP Support Programs Manager, on the Powerful Impact of the Quality of Life Respite Grant

CurePSP Strengthens Team with Director of Development and Associate Director of Scientific Affairs and Partnerships

Rich Spain Feels Right at Home as the Inaugural Director of Development

CurePSP extends its partnership with the Rainwater Charitable Foundation to accelerate the development of neuroimaging human biomarkers for progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and other primary tauopathies

CurePSP launches a new annual grant program to promote collaboration and advance clinical care research

CurePSP Expands Specialized Care Network for Rare Neurodegenerative Diseases

CurePSP is hiring! Join us in our mission!

Judy Coughlin, Wife of Former NFL Coach Tom Coughlin, Dies at 77

Protected: Neuro2022

Lecanemab for Alzheimer’s: “Proof of Principle” for PSP, CBD and MSA

Doing it for John: Bonelli Music Bash Returns for a Seventh Straight Year

CurePSP Joins the Unified Parkinson’s Advocacy Council

The Ream Family Marches Past Their Goals

CurePSP Summer Newsletter Out Now

For Carepartners, No Moment is More Important Than the Present

Through the generosity of the Light of Day Foundation, CurePSP has received a matching grant of $50,000!

Dr. John Steele, Fondly Remembered

Andy Maus Assumes Board Chair Ready for Progress

Diane Deaver Keeps it Moving Through her Quilts and Poetry

The AMULET study: A clinical research study for people living with MSA

CurePSP Centers of Care Lean on Each Other to Improve Care of PSP, CBD and MSA

CurePSP Elects Senior Healthcare Executive as Its Board Chair

Ken’s Resilience: A Shared Ride for Hope and Support

Checking in on Previously Funded Venture Grants: Where Are They Now?

Marty Rimestad Finds New Ways to Explore the Outdoors

Dr. Sally Temple Looks Ahead

Marco Island Takes its Biggest Step Towards a Cure Yet

CurePSP appoints former UNC Movement Disorders Center coordinator to its top programs position

CurePSP funds four new grants to advance treatment of prime of life neurodegeneration

CurePSP appoints Dr. Kristophe Diaz as the foundation’s chief executive

CurePSP’s clinical guide to rare neurodegenerative conditions is published by leading neurology journal

FAQ on FDA Approval of Aducanumab

VA plans expansion of benefits for disability claims for conditions related to certain toxic exposures

CurePSP awards three new Venture Grants for the study of PSP and CBD

CurePSP and the Rainwater Charitable Foundation partner to support a collaborative biobanking platform for frontotemporal dementia research

UCB pauses the development of bepranemab for progressive supranuclear palsy

Advisory on COVID-19 vaccines and PSP, CBD, and MSA from Lawrence I. Golbe, MD

CurePSP Partners With Rainwater to Support Pioneering Neurodegeneration Research

Promotus Launched as Global Alliance of PSP and CBD NGO’s

CurePSP Cancels In-Person Events

Scientific American Article Cites Tau Protein as Linchpin to Finding Neurodegeneration Cure

Update Regarding COVID-19 Virus

CurePSP’s approach during the coronavirus outbreak

Advisory on Coronavirus From Lawrence I. Golbe, MD

Biogen Ends Trial of Its Drug for PSP

CurePSP Image Library

AbbVie Ends Tau Antibody Study

CurePSP Awards Seven New Research Grants